179 related articles for article (PubMed ID: 6820883)
21. Polyamine depletion-mediated effects on murine odontogenesis are dependent on tooth developmental stage and culture conditions.
Gritli-Linde A; Ruch JV; Linde A
Int J Dev Biol; 1995 Apr; 39(2):383-93. PubMed ID: 7669549
[TBL] [Abstract][Full Text] [Related]
22. Combined therapy of polyamine antimetabolites and antitumor drugs for human gastric cancer xenotransplanted into nude mice.
Fujimoto S; Igarashi K; Shrestha RD; Miyazaki M; Endoh F; Ohta M; Togawa Y; Okui K
Jpn J Surg; 1986 Mar; 16(2):133-9. PubMed ID: 2941608
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer.
Herr HW; Kleinert EL; Relyea NM; Whitmore WF
Cancer; 1984 Mar; 53(6):1294-8. PubMed ID: 6420041
[TBL] [Abstract][Full Text] [Related]
24. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
25. Experimental chemotherapy in a transplantable renal adenocarcinoma. I: Effects of some inhibitors of polyamine synthesis.
Dunzendorfer U; Kleinert E; Whitmore WF
Urol Int; 1983; 38(3):162-5. PubMed ID: 6408777
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
27. Some effects of inhibitors of polyamine synthesis on experimental prostatic cancer.
Dunzendorfer U; Releyea N; Whitmore WF; Fogh J; Balis ME
Arzneimittelforschung; 1984; 34(1):36-9. PubMed ID: 6422951
[TBL] [Abstract][Full Text] [Related]
28. Regulation of epidermal proliferation in mouse epidermis by combination of difluoromethyl ornithine (DFMO) and methylglyoxal bis(guanylhydrazone) (MGBG).
McCullough JL; Peckham P; Klein J; Weinstein GD; Jenkins JJ
J Invest Dermatol; 1985 Dec; 85(6):518-21. PubMed ID: 3934288
[TBL] [Abstract][Full Text] [Related]
29. Comparison of specificity of inhibition of polyamine synthesis in bovine lymphocytes by ethylglyoxal bis(guanylhydrazone) and methylglyoxal bis(guanylhydrazone).
Igarashi K; Porter CW; Morris DR
Cancer Res; 1984 Nov; 44(11):5326-31. PubMed ID: 6488187
[TBL] [Abstract][Full Text] [Related]
30. A novel anticancer treatment for xenoplanted human gastric cancer using polyamine antimetabolites in a low polyamine diet.
Shrestha RD; Fujimoto S; Okui K
Surg Today; 1992; 22(2):137-42. PubMed ID: 1498492
[TBL] [Abstract][Full Text] [Related]
31. Effect of epidermal polyamine depletion on the accumulation of methylglyoxal bis(guanylhydrazone) in mouse skin.
Käpyaho K; Linnamaa K; Jänne J
J Invest Dermatol; 1982 May; 78(5):391-4. PubMed ID: 6802903
[TBL] [Abstract][Full Text] [Related]
32. Delayed sensitization to heat by inhibitors of polyamine-biosynthetic enzymes.
Fuller DJ; Gerner EW
Cancer Res; 1982 Dec; 42(12):5046-9. PubMed ID: 6814750
[TBL] [Abstract][Full Text] [Related]
33. Combined use of 2-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in normal and leukemia-bearing mice.
Seppänen P; Alhonen-Hongisto L; Jänne J
Cancer Lett; 1983 Feb; 18(1):1-10. PubMed ID: 6402294
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of melanotic expression in murine melanoma cells exposed to polyamine antimetabolites.
Käpyaho K; Jänne J
Biochem Biophys Res Commun; 1983 May; 113(1):18-23. PubMed ID: 6407478
[TBL] [Abstract][Full Text] [Related]
35. Physiological effects in bovine lymphocytes of inhibiting polyamine synthesis with ethylglyoxal bis(guanylhydrazone).
Igarashi K; Morris DR
Cancer Res; 1984 Nov; 44(11):5332-7. PubMed ID: 6435867
[TBL] [Abstract][Full Text] [Related]
36. Alterations in bone marrow and blood mononuclear cell polyamine and methylglyoxal bis(guanylhydrazone) levels: phase I evaluation of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) treatment of human hematological malignancies.
Maddox AM; Freireich EJ; Keating MJ; Haddox MK
Cancer Res; 1988 Mar; 48(5):1367-73. PubMed ID: 3124958
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of DNA and protein synthesis in UV-irradiated mouse skin by 2-difluoromethylornithine, methylglyoxal bis(guanylhydrazone), and their combination.
Käpyaho K; Lauharanta J; Jänne J
J Invest Dermatol; 1983 Aug; 81(2):102-6. PubMed ID: 6409968
[TBL] [Abstract][Full Text] [Related]
38. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
39. Difluoromethylornithine and ethylglyoxal bis(guanylhydrazone) as inhibitors of human renal carcinoma cell proliferation and polyamine metabolism.
Sjöholm A; Larsson R; Nygren P
Anticancer Res; 1993; 13(4):979-83. PubMed ID: 8352568
[TBL] [Abstract][Full Text] [Related]
40. Increased rate of tumor cell death caused by polyamine synthesis inhibitors.
Oredsson SM; Linden M; Heby O
Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 47(2):131-8. PubMed ID: 6151293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
